Northwestern Memorial Hospital; Clinical Research Unit

Chicago, Illinois 60611

1 studies enrolling now · 6 studies all time

What they study most

Hepatitis C Virus Infection, Interstitial Lung Disease, Nonalcoholic Steatohepatitis, Nonalcoholic Steatohepatitis (NASH), Primary Sclerosing Cholangitis, Progressive Pulmonary Fibrosis

Studies at this site

• Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF) — Recruiting now
• Study of Cilofexor in Adults With Primary Sclerosing Cholangitis — Stopped early
• Safety and Efficacy of Selonsertib in Adults With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis — Stopped early
• Safety and Efficacy of Selonsertib in Adults With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) — Stopped early
• Evaluate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 Weeks in Participants With Chronic HCV Infection and Child-Pugh-Turcotte Class C Cirrhosis — Completed
• Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH) — Completed